Norepinephrine-induced myeloid-derived suppressor cells block T-cell responses via generation of reactive oxygen species

Immunopharmacology and Immunotoxicology

Volumn 37, Issue 4, 2015, Pages 359-365

  Liu, Yufeng ^a   Wei, Jianyang ^a   Guo, Guanghui ^b   Zhou, Jie ^a,c  

^a SUN YAT SEN UNIVERSITY   (China)

^b No 371 Central Hospital of People's Liberation Army   (China)

^c SUN YAT SEN UNIVERSITY   (China)

Author keywords

Immunosuppression function; myeloid derived suppressor cells; norepinephrine

Indexed keywords

CATALASE; NITRIC OXIDE; NORADRENALIN; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; AGENTS INTERACTING WITH TRANSMITTER, HORMONE OR DRUG RECEPTORS;

ARTICLE; BONE MARROW CELL; CELL DIFFERENTIATION; CELL ISOLATION; CELL PROLIFERATION; COCULTURE; ENZYME ACTIVITY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IN VITRO STUDY; MYELOID DERIVED SUPPRESSOR CELL; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SUPPRESSOR CELL; T LYMPHOCYTE; BIOSYNTHESIS; CELL LINE; CYTOLOGY; DRUG EFFECTS; IMMUNOLOGY; METABOLISM; MYELOID PROGENITOR CELL;

CELL DIFFERENTIATION; CELL LINE; CELL PROLIFERATION; FLOW CYTOMETRY; HUMANS; MYELOID CELLS; MYELOID PROGENITOR CELLS; NEUROTRANSMITTER AGENTS; NITRIC OXIDE; NOREPINEPHRINE; REACTIVE OXYGEN SPECIES; T-LYMPHOCYTES;

EID: 84938898457     PISSN: 08923973     EISSN: 15322513     Source Type: Journal    
DOI: 10.3109/08923973.2015.1059442     Document Type: Article

References (26)

1. Gabrilovich DI, Ostrand-Rosenberg S, Bronte V. Coordinated regulation of myeloid cells by tumours. Nat Rev Immunol 2012;12:253-268.
2. Khaled YS, Ammori BJ, Elkord E. Myeloid-derived suppressor cells in cancer: recent progress and prospects. Immunol Cell Biol 2013;91:493-502.
3. Kostlin N, Kugel H, Spring B, et al. Granulocytic myeloid derived suppressor cells expand in human pregnancy and modulate T-cell responses. Eur J Immunol 2014;44:2582-2591.
4. Youn JI, Gabrilovich DI. The biology of myeloid-derived suppressor cells: the blessing and the curse of morphological and functional heterogeneity. Eur J Immunol 2010;40:2969-2975.
5. Gabrilovich DI, Nagaraj S. Myeloid-derived suppressor cells as regulators of the immune system. Nat Rev Immunol 2009;9:162-174.
6. Ostrand-Rosenberg S, Sinha P. Myeloid-derived suppressor cells: linking inflammation and cancer. J Immunol 2009;182:4499-4506.
7. Evans DL, Charney DS, Lewis L, et al. Mood disorders in the medically ill: scientific review and recommendations. Biol Psychiatry 2005;58:175-189.
8. Evans DL, Ten HT, Douglas SD, et al. Association of depression with viral load, CD8 T lymphocytes, and natural killer cells in women with HIV infection. Am J Psychiatry 2002;159:1752-1759.
9. Li Y, Xiao B, Qiu W, et al. Altered expression of CD4(+)CD25(+) regulatory T cells and its 5-HT(1a) receptor in patients with major depression disorder. J Affect Disord 2010;124:68-75.
10. Myint AM, Leonard BE, Steinbusch HW, et al. Th1, Th2, and Th3 cytokine alterations in major depression. J Affect Disord 2005;88:167-173.
11. Gilmor ML, Owens MJ, Nemeroff CB. Inhibition of norepinephrine uptake in patients with major depression treated with paroxetine. Am J Psychiatry 2002;159:1702-1710.
12. Kohm AP, Sanders VM. Norepinephrine: a messenger from the brain to the immune system. Immunol Today 2000;21:539-542.
13. Li Z, Oben JA, Yang S, et al. Norepinephrine regulates hepatic innate immune system in leptin-deficient mice with nonalcoholic steatohepatitis. Hepatology 2004;40:434-441.
14. Kohm AP, Sanders VM. Norepinephrine: a messenger from the brain to the immune system. Immunol Today 2000;21:539-542.
15. Wu J, Zhang R, Tang N, et al. Dopamine inhibits the function of Gr-1+CD115+ myeloid-derived suppressor cells through D1-like receptors and enhances anti-tumor immunity. J Leukoc Biol 2015;97:191-200.
16. Qin A, Cai W, Pan T, et al. Expansion of monocytic myeloid-derived suppressor cells dampens T cell function in HIV-1-seropositive individuals. J Virol 2013;87:1477-1490.
17. Talmadge JE, Gabrilovich DI. History of myeloid-derived suppressor cells. Nat Rev Cancer 2013;13:739-752.
18. Marigo I, Bosio E, Solito S, et al. Tumor-induced tolerance and immune suppression depend on the C/EBPbeta transcription factor. Immunity 2010;32:790-802.
19. Qu P, Boelte KC, Lin PC. Negative regulation of myeloid-derived suppressor cells in cancer. Immunol Invest 2012;41:562-580.
20. Ugel S, Delpozzo F, Desantis G, et al. Therapeutic targeting of myeloid-derived suppressor cells. Curr Opin Pharmacol 2009;9:470-481.
21. Sanders VM, Baker RA, Ramer-Quinn DS, et al. Differential expression of the beta2-adrenergic receptor by Th1 and Th2 clones: implications for cytokine production and B cell help. J Immunol 1997;158:4200-4210.
22. Swanson MA, Lee WT, Sanders VM. IFN-gamma production by Th1 cells generated from naive CD4+ T cells exposed to norepinephrine. J Immunol 2001;166:232-240.
23. Kohm AP, Sanders VM. Norepinephrine and beta 2-adrenergic receptor stimulation regulate CD4+ T and B lymphocyte function in vitro and in vivo. Pharmacol Rev 2001;53:487-525.
24. Deo SH, Jenkins NT, Padilla J, et al. Norepinephrine increases NADPH oxidase-derived superoxide in human peripheral blood mononuclear cells via alpha-adrenergic receptors. Am J Physiol Regul Integr Comp Physiol 2013;305:R1124-R1132.
25. Schmitz G, Herr AS, Rothe G. T-lymphocytes and monocytes in atherogenesis. HERZ 1998;23:168-177.
26. Chon H, Verhaar MC, Koomans HA, et al. Role of circulating karyocytes in the initiation and progression of atherosclerosis. Hypertension 2006;47:803-810.